tirzepatide in tablets Oral The dual Injectable Tirzepatide | Compounded GLP-1/GIP

Activating both pathways simultaneously is the mechanistic rationale studied for dual-incretin therapy

Well, GLP-1s are notorious for causing muscle loss Folks tend to bring their bad eating habits with them when they go on GLP-1s

Patients who initiated semaglutide or tirzepatide had over a 40% lower risk of being hospitalized due to heart failure or all-cause mortality compared to sitagliptin, which served as a placebo proxy, Nils Kr ger, MD, research fellow in the division of pharmacoepidemiology and pharmacoeconomics at Brigham and Womens Hospital and Harvard Medical School and also physician scientist at TUM University Hospital German Heart Centre in Munich, said during a presentation of the results at the recent European Society of Cardiology Congress

Summary of Stroke Prevention in AFib In AFib management, stroke prevention is of utmost importance

Medical guidance is essential before making individual decisions

Meta-analysis of 59 studies demonstrating that switching APs to agents with lower weight gain potential can improve weight profiles and other cardiometabolic outcomes